David L. Barker - 14 May 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Reporting relationship: Director
Issuer ticker: BNGO
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 18:14:47 UTC
Prior SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Jonathan V. Dixon, Attorney-in-Fact

Key filing fact

David L. Barker filed Form 4 for Bionano Genomics, Inc. (BNGO) on 14 May 2026.

Key facts

This page summarizes David L. Barker's Form 4 filing for Bionano Genomics, Inc. (BNGO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 May 2026, 18:14.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001189124 Primary reporting owner

BARKER DAVID L

Relationship: Director
Address: C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Signature date: 14 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BNGO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +9,149
Change %
Price: $0.000000^*
Shares after: 9,149
Date: 14 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,149
Exercise price: $1.19
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).